123 related articles for article (PubMed ID: 22431710)
1. Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.
Yeo CW; Ng FS; Chai C; Tan JM; Koh GR; Chong YK; Koh LW; Foong CS; Sandanaraj E; Holbrook JD; Ang BT; Takahashi R; Tang C; Lim KL
Cancer Res; 2012 May; 72(10):2543-53. PubMed ID: 22431710
[TBL] [Abstract][Full Text] [Related]
2. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
3. Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.
Lin DC; Xu L; Chen Y; Yan H; Hazawa M; Doan N; Said JW; Ding LW; Liu LZ; Yang H; Yu S; Kahn M; Yin D; Koeffler HP
Cancer Res; 2015 May; 75(9):1815-27. PubMed ID: 25877876
[TBL] [Abstract][Full Text] [Related]
4. Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells.
Tay SP; Yeo CW; Chai C; Chua PJ; Tan HM; Ang AX; Yip DL; Sung JX; Tan PH; Bay BH; Wong SH; Tang C; Tan JM; Lim KL
J Biol Chem; 2010 Sep; 285(38):29231-8. PubMed ID: 20630868
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
Gao J; Zhang JY; Li YH; Ren F
Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
[TBL] [Abstract][Full Text] [Related]
6. Expression profile of parkin isoforms in human gliomas.
Maugeri G; D'Amico AG; Magro G; Salvatorelli L; Barbagallo GM; Saccone S; Drago F; Cavallaro S; D'Agata V
Int J Oncol; 2015 Oct; 47(4):1282-92. PubMed ID: 26238155
[TBL] [Abstract][Full Text] [Related]
7. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells.
Cuevas P; Díaz-González D; Sánchez I; Lozano RM; Giménez-Gallego G; Dujovny M
Neurol Res; 2006 Mar; 28(2):127-30. PubMed ID: 16551428
[TBL] [Abstract][Full Text] [Related]
8. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
9. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas.
Liu W; Lv G; Li Y; Li L; Wang B
J Exp Clin Cancer Res; 2011 Aug; 30(1):76. PubMed ID: 21843312
[TBL] [Abstract][Full Text] [Related]
11. Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner.
Wang G; Sai K; Gong F; Yang Q; Chen F; Lin J
Mol Med Rep; 2014 May; 9(5):1799-805. PubMed ID: 24626950
[TBL] [Abstract][Full Text] [Related]
12. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
13. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.
Di Desidero T; Fioravanti A; Orlandi P; Canu B; Giannini R; Borrelli N; Man S; Xu P; Fontanini G; Basolo F; Kerbel RS; Francia G; Danesi R; Bocci G
J Clin Endocrinol Metab; 2013 Sep; 98(9):E1465-73. PubMed ID: 23969186
[TBL] [Abstract][Full Text] [Related]
15. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of proteolysis-mediated cyclin E regulation by alternatively spliced Parkin in human colorectal cancers.
Ikeuchi K; Marusawa H; Fujiwara M; Matsumoto Y; Endo Y; Watanabe T; Iwai A; Sakai Y; Takahashi R; Chiba T
Int J Cancer; 2009 Nov; 125(9):2029-35. PubMed ID: 19585504
[TBL] [Abstract][Full Text] [Related]
17. Differential response of glioma cells to FOXO1-directed therapy.
Lau CJ; Koty Z; Nalbantoglu J
Cancer Res; 2009 Jul; 69(13):5433-40. PubMed ID: 19549905
[TBL] [Abstract][Full Text] [Related]
18. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor.
Houshmandi SS; Surace EI; Zhang HB; Fuller GN; Gutmann DH
Neurology; 2006 Nov; 67(10):1863-6. PubMed ID: 17130425
[TBL] [Abstract][Full Text] [Related]
20. Parkin as a tumor suppressor gene for hepatocellular carcinoma.
Fujiwara M; Marusawa H; Wang HQ; Iwai A; Ikeuchi K; Imai Y; Kataoka A; Nukina N; Takahashi R; Chiba T
Oncogene; 2008 Oct; 27(46):6002-11. PubMed ID: 18574468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
